机构:[1]Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.[2]Department of Emergency, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.大德路总院急诊科大德路总院急诊科广东省中医院[3]Department of Clinical Epidemiology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.广东省中医院[4]Intensive Care Unit, Traditional Chinese Medicine Hospital Dianjiang, Chongqing, PR China.[5]Guangdong Provincial Key Laboratory of Research on Emergency in TCM, Guangzhou, PR China.[6]Department of Family Medicine and Community Health, University of Wisconsin, Madison, WI, USA.[7]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.大德路总院肾内科大德路总院肾内科广东省中医院[8]Department of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, PR China.[9]Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
The Wisconsin upper respiratory symptom survey (WURSS) is a validated English questionnaire to evaluate the quality of life and severity of upper respiratory tract infections (URTIs). We aimed to develop a Mandarin Chinese version of WURSS-24 (WURSS-24-C) and evaluate its reliability, validity and minimal important difference (MID).The WURSS-24-C was developed using the forward-backward translation procedure. People with URTIs' symptoms within 48 h of onset were recruited and asked to fill in the WURSS-24-C daily for up to 14 d. Exploratory and confirmatory factor analyses were used to suggest domains. The 8-Item Short Form Health Survey (SF-8) assessing general mental and physical health was used to assess validity. Reliability estimated by Cronbach's alpha and mean day-to-day change for those indicating minimal improvement as MID were evaluated.The WURSS-24-C was found to be acceptable, relevant, and easy to complete in cognitive debriefing interviews. A total number of 300 participants (age 28.4 ± 9.3, female 70%) were monitored for 2500 person-days. Four domains (activity and function, systemic symptoms, nasal symptoms and throat symptoms) of the WURSS-24-C were confirmed (comparative fit index [CFI] = 0.93). The reliability of this 4-domain-structure is good (Cronbach's alphas varied from 0.849 to 0.943). Convergent validity is moderate (Pearson correlation coefficients between daily WURSS-24-C and the SF-8 were -0.780 and -0.721, for the SF-8 physical and mental health, respectively). Estimates of MID for individual items varied from -0.41 to -1.14.The WURSS-24-C is a reliable and valid questionnaire for assessing illness-specific quality-of-life health status in Chinese-speaking patients with URTIs.Key messagesThe Wisconsin upper respiratory symptom survey (WURSS) series are patient-oriented questionnaire instruments assessing the quality of life and severity of upper respiratory tract infections (URTIs).The WURSS-24 was translated into Mandarin Chinese using the forward-backward translation procedure, and evaluated its validity, reliability and minimal important difference (MID) in 300 Chinese participants with URTIs.The WURSS-24 Chinese version (WURSS-24-C) seems to be a reliable and valid questionnaire for assessing illness-specific quality-of-life health status in Chinese patients with URTIs.
基金:
China National Science and
Technology Major Project, NO:2017ZX10305501- 006;
Guangdong Provincial Key Laboratory of T CM Research on
Emergency, NO: 2017B030314176; Evidence-based Capacity
Building Project of Traditional Chinese Medicine, NO:
2019XZZX-LG003; Collaborative innovation team project of
Guangzhou University of Chinese Medicine, NO:2021XK06
and 2021XK49; and Guangzhou Municipal Science and
Technology Bureau, NO: 201803010121. G.S. acknowledges
support from National Nature Science Foundation of China,
China, NO: 82004205; China Postdoctoral Science
Foundation, China, NO: 2020M672741 and 2020T Q0137; the
Karolinska Institutet research funds, Sweden, NO: 2020-
01616; the Science and Technology Research Fund from
Guangdong provincial hospital of Chinese medicine, China,
No: YN2018QL08.
第一作者机构:[1]Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.[2]Department of Emergency, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.[2]Department of Emergency, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.[5]Guangdong Provincial Key Laboratory of Research on Emergency in TCM, Guangzhou, PR China.[7]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China.[8]Department of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Nanfang Hospital, Southern Medical University, Guangzhou, PR China.[9]Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.[*1]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China[*2]Department of Emergency, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 111 Dade Road, Yuexiu District, Guangzhou City, 510120 PR China
推荐引用方式(GB/T 7714):
Wang Yuanyuan,He Zehui,Chen Simin,et al.Validation of the Wisconsin upper respiratory symptom survey-24, Chinese version.[J].ANNALS OF MEDICINE.2022,54(1):655-665.doi:10.1080/07853890.2022.2043559.
APA:
Wang Yuanyuan,He Zehui,Chen Simin,Liu Yuntao,Li Fang...&Stålsby Lundborg Cecilia.(2022).Validation of the Wisconsin upper respiratory symptom survey-24, Chinese version..ANNALS OF MEDICINE,54,(1)
MLA:
Wang Yuanyuan,et al."Validation of the Wisconsin upper respiratory symptom survey-24, Chinese version.".ANNALS OF MEDICINE 54..1(2022):655-665